I-32: Avoiding OHSS in Ovarian Stimulation

author

Abstract:

Multiple pregnancies and ovarian hyper stimulation syndrome (OHSS) are the most serious complications of ovarian stimulation and IVF. Indeed, they are more or less the only ones. OHSS can effectively be prevented in three stages: Before stimulation, during stimulation and at ET. Before stimulation patients should be assessed as to age, the ovarian follicular count and/or anti mullerian hormone (AMH). A correct starting dose of FSH should hence be administered. During stimulation and ET many different strategies can be applied: 1. Low dose stimulation: The disadvantage is fewer oocytes and fewer embryos to freeze. 2. GnRH antagonist protocol with oocyte maturation by administering a GnRH analogue instead of HCG. Disadvantage is the handling of the luteal phase after ET in the fresh cycle. 3. Coasting before HCG is administered. Disadvantage is that it does not always work and requires a lot of experience. 4. No fresh ET, freezing of all appropriate embryos. Disadvantage is that it does not influence the first phase OHSS. 5. Dopamin agonist prescribed before HCG is administered. Disadvantage is that it does not affect OHSS if pregnancy occurs. 6. Transferring no more than one embryo. Disadvantage,if any, is that it may decrease the pregnancy rate. 7. Cancelling the cycle. These tools make it perfectly possible to avoid any serious OHSS. Given a good freezing programme, the disadvantages are minor. Serious OHSS should no longer be a part of IVF.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

Avoiding OHSS: Controlled Ovarian Low-Dose Stimulation in Women with PCOS.

The polycystic ovary syndrome is a common endocrine disorder which influences outcome and potential risks involved with controlled ovarian stimulation for artificial reproductive techniques (ART). Concrete practical recommendations for the dosage of gonadotropins, the preferred protocol and preventive methods to avoid ovarian hyperstimulation syndrome (OHSS) are lacking. We present retrospectiv...

full text

I-32: Management of Diminished Ovarian Reserve

The standard goal of all fertility treatments is the improvement of pregnancy rates in infertile patients. Within the last 20 years, ovulation induction has contributed to the success of assisted reproduction techniques e.g. in vitro fertilization (IVF) and embryo-transfer (ET). The efficacy of these techniques depends on a personalized protocol of controlled ovarian hyperstimulation (COH) and ...

full text

I-24: Individualized Controlled Ovarian Stimulation (iCOS)

Background: With the recent development of recombinant gonadotropins (FSH and LH), it has become possible to further adjust the stimulation protocol according to the expected needs of the patient. In this respect, the possible beneficial role of exogenous LH activity supplementation for stimulated ART cycles has received increasing attention. According to the two-cell, two- gonadotropin theory,...

full text

I-37: Controlled Ovarian Stimulation in Cancer Patients

Recent advances in the technology of vitrification of human oocytes and embryos have increased the opportunities for fertility preservation in cancer patients. Ovarian stimulation in this group of patients is associated with some unique challenges. A controversy in this field rotated around the hypothesis that the transient elevations of estrogen during an IVF cycle may stimulate tumor growth; ...

full text

I-36: The Role of LH in Controlled Ovarian Stimulation

It is known that the follicular selection and final stages of follicular maturation are equal if not more dependent on low circulating levels of LH.In addition to stimulating production of thecal androgens as substrate for estrogen synthesis, LH stimulates granulose cell via LH receptors induced by FSH and estrogen in larger but not smaller follicles. The data from numerous assisted reproductio...

full text

I-22: Fertility Preservation and Ovarian Stimulation in Cancer Patients

Cancer is not uncommon and no longer considered to be an incurable disorder. 10% of cancer cases occur under the age of 45. There is a remarkable improvement in treatment and survival rates. Today women have been delaying initiation of childbearing because the incidence of most cancers increases with age. Delayed childbearing results in more female cancer survivors. As a consequence there is an...

full text

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}


Journal title

volume 6  issue 2

pages  -

publication date 2012-09-01

By following a journal you will be notified via email when a new issue of this journal is published.

Keywords

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023